Ole Andreas Halvorsen - Viking Global Investors Portfolio
| Period Date | Mar 31, 2025 | |
| Filing Date | May 15, 2025 | |
| Total Stocks | 91 | |
| Portfolio Value | $31.48B |
Viking Global Investors Activity
| Date | Symbol | Type | Quantity |
|---|---|---|---|
Q2 2022Jun 30, 2022 | OLPX Olaplex Holdings, Inc. | Sell - Position Exit | -1,613,189-100.0% |
Q2 2022Jun 30, 2022 | JD JD.com, Inc. | Sell - Position Exit | -1,748,330-100.0% |
Q2 2022Jun 30, 2022 | PRCT PROCEPT BioRobotics Corporation | Sell | -2,113,892-57.8% |
Q2 2022Jun 30, 2022 | THC Tenet Healthcare Corporation | Sell - Position Exit | -2,233,647-100.0% |
Q2 2022Jun 30, 2022 | ZI ZoomInfo Technologies Inc. | Sell - Position Exit | -2,644,137-100.0% |
Q2 2022Jun 30, 2022 | MTCH Match Group, Inc. | Sell - Position Exit | -2,744,468-100.0% |
Q2 2022Jun 30, 2022 | BEKE KE Holdings Inc | Sell | -3,029,618-22.5% |
Q2 2022Jun 30, 2022 | OTIS Otis Worldwide Corporation | Sell - Position Exit | -3,538,164-100.0% |
Q2 2022Jun 30, 2022 | GE GE Aerospace | Sell | -4,058,177-31.7% |
Q2 2022Jun 30, 2022 | TMUS T-Mobile US, Inc. | Sell | -4,247,782-31.7% |
Q2 2022Jun 30, 2022 | LI Li Auto Inc. | Sell - Position Exit | -6,000,478-100.0% |
Q2 2022Jun 30, 2022 | CMCSA Comcast Corporation | Sell - Position Exit | -14,078,668-100.0% |
Q1 2022Mar 31, 2022 | BEKE KE Holdings Inc | Buy | +10,519,869+360.2% |
Q1 2022Mar 31, 2022 | AMLX Amylyx Pharmaceuticals, Inc. | Buy - Position Entry | +7,170,536 |
Q1 2022Mar 31, 2022 | FTV Fortive Corporation | Buy | +3,548,215+41.8% |
Q1 2022Mar 31, 2022 | OTIS Otis Worldwide Corporation | Buy - Position Entry | +3,538,164 |
Q1 2022Mar 31, 2022 | IFF International Flavors & Fragran | Buy | +3,286,245+643.1% |
Q1 2022Mar 31, 2022 | HDB HDFC Bank Limited | Buy | +2,220,379+45.8% |
Q1 2022Mar 31, 2022 | MA Mastercard Incorporated | Buy - Position Entry | +1,793,488 |
Q1 2022Mar 31, 2022 | LI Li Auto Inc. | Buy | +1,514,493+33.8% |
Q1 2022Mar 31, 2022 | MET MetLife, Inc. | Buy - Position Entry | +1,362,166 |
Q1 2022Mar 31, 2022 | UNM Unum Group | Buy - Position Entry | +1,137,645 |
Q1 2022Mar 31, 2022 | CLDX Celldex Therapeutics, Inc. | Buy | +1,088,766+143.7% |
Q1 2022Mar 31, 2022 | PGR Progressive Corporation (The) | Buy - Position Entry | +1,037,306 |
Q1 2022Mar 31, 2022 | MMC Marsh & McLennan Companies, Inc | Buy | +989,073+78.4% |
Q1 2022Mar 31, 2022 | NTLA Intellia Therapeutics, Inc. | Buy | +889,224+56.3% |
Q1 2022Mar 31, 2022 | BMRN BioMarin Pharmaceutical Inc. | Buy | +882,446+30.7% |
Q1 2022Mar 31, 2022 | MTCH Match Group, Inc. | Buy | +844,894+44.5% |
Q1 2022Mar 31, 2022 | PVH PVH Corp. | Buy | +773,566+100.6% |
Q1 2022Mar 31, 2022 | CTLT Catalent, Inc. | Buy | +754,290+66.2% |